7 results on '"Gonzalez, Alfonso Otero"'
Number of results to display per page
Search Results
2. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review
- Author
-
Brück, Katharina, Jager, Kitty J., Dounousi, Evangelia, Kainz, Alexander, Nitsch, Dorothea, Ärnlöv, Johan, Rothenbacher, Dietrich, Browne, Gemma, Capuano, Vincenzo, Ferraro, Pietro Manuel, Ferrieres, Jean, Gambaro, Giovanni, Guessous, Idris, Hallan, Stein, Kastarinen, Mika, Navis, Gerjan, Gonzalez, Alfonso Otero, Palmieri, Luigi, Romundstad, Solfrid, Spoto, Belinda, Stengel, Benedicte, Tomson, Charles, Tripepi, Giovanni, Völzke, Henry, Wie[COMBINING CEDILLA]cek, Andrzej, Gansevoort, Ron, Schöttker, Ben, Wanner, Christoph, Vinhas, Jose, Zoccali, Carmine, Van Biesen, Wim, Stel, Vianda S., Jousilahti, Pekka, Helmer, Catherine, Metzger, Marie, Ruidavets, Jean Bernard, Bongard, Vanina, Koenig, Wolfgang, Denkinger, Michael D., Brenner, Hermann, Saum, Kai-Uwe, Nauck, Matthias, Stracke, Sylvia, Perry, Ivan, Eustace, Joseph, Lupo, Antonio, Donfrancesco, Chiara, Palleschi, Simonetta, Lamaida, Norman, Capuano, Ernesto, Sinkeler, Steef, Wolffenbuttel, B.H.R., Bakker, Stephan J.L., Aasarød, Knut, Holmen, Jostein, Chudek, Jerzy, Malgorzata, Mossakowska, Gardete-Correia, Luis, Raposo, João F., de Francisco, A.L. Martin, Gayoso Diz, P., Nerpin, Elisabet, Lind, Lars, Bochud, Murielle, Gaspoz, Jean-Michel, Fletcher, Astrid, Roderick, Paul, Van Pottelbergh, Gijs, Van Der Tol, Arjan, Hadjadj, Samy, and Stojceva-Taneva, Olivera
- Published
- 2015
- Full Text
- View/download PDF
3. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review
- Author
-
Brück, Katharina, Jager, Kitty J., Dounousi, Evangelia, Kainz, Alexander, Nitsch, Dorothea, Ärnlöv, Johan, Rothenbacher, Dietrich, Browne, Gemma, Capuano, Vincenzo, Ferraro, Pietro Manuel, Ferrieres, Jean, Gambaro, Giovanni, Guessous, Idris, Hallan, Stein, Kastarinen, Mika, Navis, Gerjan, Gonzalez, Alfonso Otero, Palmieri, Luigi, Romundstad, Solfrid, Spoto, Belinda, Stengel, Benedicte, Tomson, Charles, Tripepi, Giovanni, Völzke, Henry, Wiȩcek, Andrzej, Gansevoort, Ron, Schöttker, Ben, Wanner, Christoph, Vinhas, Jose, Zoccali, Carmine, Van Biesen, Wim, Stel, Vianda S., Jousilahti, Pekka, Helmer, Catherine, Metzger, Marie, Ruidavets, Jean Bernard, Bongard, Vanina, Koenig, Wolfgang, Denkinger, Michael D., Brenner, Hermann, Saum, Kai-Uwe, Nauck, Matthias, Stracke, Sylvia, Perry, Ivan, Eustace, Joseph, Lupo, Antonio, Donfrancesco, Chiara, Palleschi, Simonetta, Lamaida, Norman, Capuano, Ernesto, Sinkeler, Steef, Wolffenbuttel, B.H.R., Bakker, Stephan J.L., Aasarød, Knut, Holmen, Jostein, Chudek, Jerzy, Malgorzata, Mossakowska, Gardete-Correia, Luis, Raposo, João F., de Francisco, A.L. Martin, Gayoso Diz, P., Nerpin, Elisabet, Lind, Lars, Bochud, Murielle, Gaspoz, Jean-Michel, Fletcher, Astrid, Roderick, Paul, Van Pottelbergh, Gijs, Van Der Tol, Arjan, Hadjadj, Samy, and Stojceva-Taneva, Olivera
- Subjects
urologic and male genital diseases ,female genital diseases and pregnancy complications - Abstract
Background Many publications report the prevalence of chronic kidney disease (CKD) in the general population. Comparisons across studies are hampered as CKD prevalence estimations are influenced by study population characteristics and laboratory methods. Methods For this systematic review, two researchers independently searched PubMed, MEDLINE and EMBASE to identify all original research articles that were published between 1 January 2003 and 1 November 2014 reporting the prevalence of CKD in the European adult general population. Data on study methodology and reporting of CKD prevalence results were independently extracted by two researchers. Results We identified 82 eligible publications and included 48 publications of individual studies for the data extraction. There was considerable variation in population sample selection. The majority of studies did not report the sampling frame used, and the response ranged from 10 to 87%. With regard to the assessment of kidney function, 67% used a Jaffe assay, whereas 13% used the enzymatic assay for creatinine determination. Isotope dilution mass spectrometry calibration was used in 29%. The CKD-EPI (52%) and MDRD (75%) equations were most often used to estimate glomerular filtration rate (GFR). CKD was defined as estimated GFR (eGFR)
- Published
- 2017
4. CKD prevalence varies across the European general population
- Author
-
Brück, Katharina, Stel, Vianda S., Gambaro, Giovanni, Hallan, Stein, Völzke, Henry, Ärnlöv, Johan, Kastarinen, Mika, Guessous, Idri, Vinhas, José, Stengel, Bénédicte, Brenner, Hermann, Chudek, Jerzy, Romundstad, Solfrid, Tomson, Charle, Gonzalez, Alfonso Otero, Bello, Aminu K., Ferrieres, Jean, Palmieri, Luigi, Browne, Gemma, Capuano, Vincenzo, Van Biesen, Wim, Zoccali, Carmine, Gansevoort, Ron, Navis, Gerjan, Rothenbacher, Dietrich, Ferraro, Pietro Manuel, Nitsch, Dorothea, Wanner, Christoph, Jager, Kitty J., Gambaro, Giovanni (ORCID:0000-0001-5733-2370), Ferraro, Pietro Manuel (ORCID:0000-0002-1379-022X), Brück, Katharina, Stel, Vianda S., Gambaro, Giovanni, Hallan, Stein, Völzke, Henry, Ärnlöv, Johan, Kastarinen, Mika, Guessous, Idri, Vinhas, José, Stengel, Bénédicte, Brenner, Hermann, Chudek, Jerzy, Romundstad, Solfrid, Tomson, Charle, Gonzalez, Alfonso Otero, Bello, Aminu K., Ferrieres, Jean, Palmieri, Luigi, Browne, Gemma, Capuano, Vincenzo, Van Biesen, Wim, Zoccali, Carmine, Gansevoort, Ron, Navis, Gerjan, Rothenbacher, Dietrich, Ferraro, Pietro Manuel, Nitsch, Dorothea, Wanner, Christoph, Jager, Kitty J., Gambaro, Giovanni (ORCID:0000-0001-5733-2370), and Ferraro, Pietro Manuel (ORCID:0000-0002-1379-022X)
- Abstract
CKD prevalence estimation is central to CKD management and prevention planning at the population level. This study estimated CKD prevalence in the European adult general population and investigated international variation in CKD prevalence by age, sex, and presence of diabetes, hypertension, and obesity. We collected data from 19 general-population studies from 13 European countries. CKD stages 1-5 was defined as eGFR<60 ml/min per 1.73 m2, as calculated by the CKD-Epidemiology Collaboration equation, or albuminuria >30 mg/g, and CKD stages 3-5 was defined as eGFR<60 ml/min per 1.73 m2. CKD prevalence was age- and sex-standardized to the population of the 27 Member States of the European Union (EU27). We found considerable differences in both CKD stages 1-5 and CKD stages 3-5 prevalence across European study populations. The adjusted CKD stages 1-5 prevalence varied between 3.31% (95% confidence interval [95% CI], 3.30% to 3.33%) inNorway and 17.3% (95% CI, 16.5% to 18.1%) in northeastGermany. The adjusted CKDstages 3-5 prevalence varied between 1.0% (95% CI, 0.7% to 1.3%) in central Italy and 5.9% (95% CI, 5.2% to 6.6%) in northeast Germany. The variation in CKD prevalence stratified by diabetes, hypertension, and obesity status followed the same pattern as the overall prevalence. In conclusion, this large-scale attempt to carefully characterize CKD prevalence in Europe identified substantial variation in CKD prevalence that appears to be due to factors other than the prevalence of diabetes, hypertension, and obesity.
- Published
- 2016
5. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review
- Author
-
Brück, Katharina, Jager, Kitty J., Dounousi, Evangelia, Kainz, Alexander, Nitsch, Dorothea, Ärnlöv, Johan, Rothenbacher, Dietrich, Browne, Gemma, Capuano, Vincenzo, Ferraro, Pietro Manuel, Ferrieres, Jean, Gambaro, Giovanni, Guessous, Idris, Hallan, Stein, Kastarinen, Mika, Navis, Gerjan, Gonzalez, Alfonso Otero, Palmieri, Luigi, Romundstad, Solfrid, Spoto, Belinda, Stengel, Benedicte, Tomson, Charles, Tripepi, Giovanni, Völzke, Henry, Wiȩcek, Andrzej, Gansevoort, Ron, Schöttker, Ben, Wanner, Christoph, Vinhas, Jose, Zoccali, Carmine, Van Biesen, Wim, Stel, Vianda S., Jousilahti, Pekka, Helmer, Catherine, Metzger, Marie, Ruidavets, Jean Bernard, Bongard, Vanina, Koenig, Wolfgang, Denkinger, Michael D., Brenner, Hermann, Saum, Kai-Uwe, Nauck, Matthias, Stracke, Sylvia, Perry, Ivan, Eustace, Joseph, Lupo, Antonio, Donfrancesco, Chiara, Palleschi, Simonetta, Lamaida, Norman, Capuano, Ernesto, Sinkeler, Steef, Wolffenbuttel, B.H.R., Bakker, Stephan J.L., Aasarød, Knut, Holmen, Jostein, Chudek, Jerzy, Malgorzata, Mossakowska, Gardete-Correia, Luis, Raposo, João F., de Francisco, A.L. Martin, Gayoso Diz, P., Nerpin, Elisabet, Lind, Lars, Bochud, Murielle, Gaspoz, Jean-Michel, Fletcher, Astrid, Roderick, Paul, Van Pottelbergh, Gijs, Van Der Tol, Arjan, Hadjadj, Samy, Stojceva-Taneva, Olivera, Brück, Katharina, Jager, Kitty J., Dounousi, Evangelia, Kainz, Alexander, Nitsch, Dorothea, Ärnlöv, Johan, Rothenbacher, Dietrich, Browne, Gemma, Capuano, Vincenzo, Ferraro, Pietro Manuel, Ferrieres, Jean, Gambaro, Giovanni, Guessous, Idris, Hallan, Stein, Kastarinen, Mika, Navis, Gerjan, Gonzalez, Alfonso Otero, Palmieri, Luigi, Romundstad, Solfrid, Spoto, Belinda, Stengel, Benedicte, Tomson, Charles, Tripepi, Giovanni, Völzke, Henry, Wiȩcek, Andrzej, Gansevoort, Ron, Schöttker, Ben, Wanner, Christoph, Vinhas, Jose, Zoccali, Carmine, Van Biesen, Wim, Stel, Vianda S., Jousilahti, Pekka, Helmer, Catherine, Metzger, Marie, Ruidavets, Jean Bernard, Bongard, Vanina, Koenig, Wolfgang, Denkinger, Michael D., Brenner, Hermann, Saum, Kai-Uwe, Nauck, Matthias, Stracke, Sylvia, Perry, Ivan, Eustace, Joseph, Lupo, Antonio, Donfrancesco, Chiara, Palleschi, Simonetta, Lamaida, Norman, Capuano, Ernesto, Sinkeler, Steef, Wolffenbuttel, B.H.R., Bakker, Stephan J.L., Aasarød, Knut, Holmen, Jostein, Chudek, Jerzy, Malgorzata, Mossakowska, Gardete-Correia, Luis, Raposo, João F., de Francisco, A.L. Martin, Gayoso Diz, P., Nerpin, Elisabet, Lind, Lars, Bochud, Murielle, Gaspoz, Jean-Michel, Fletcher, Astrid, Roderick, Paul, Van Pottelbergh, Gijs, Van Der Tol, Arjan, Hadjadj, Samy, and Stojceva-Taneva, Olivera
- Abstract
Background Many publications report the prevalence of chronic kidney disease (CKD) in the general population. Comparisons across studies are hampered as CKD prevalence estimations are influenced by study population characteristics and laboratory methods. Methods For this systematic review, two researchers independently searched PubMed, MEDLINE and EMBASE to identify all original research articles that were published between 1 January 2003 and 1 November 2014 reporting the prevalence of CKD in the European adult general population. Data on study methodology and reporting of CKD prevalence results were independently extracted by two researchers. Results We identified 82 eligible publications and included 48 publications of individual studies for the data extraction. There was considerable variation in population sample selection. The majority of studies did not report the sampling frame used, and the response ranged from 10 to 87%. With regard to the assessment of kidney function, 67% used a Jaffe assay, whereas 13% used the enzymatic assay for creatinine determination. Isotope dilution mass spectrometry calibration was used in 29%. The CKD-EPI (52%) and MDRD (75%) equations were most often used to estimate glomerular filtration rate (GFR). CKD was defined as estimated GFR (eGFR) <60 mL/min/1.73 m2 in 92% of studies. Urinary markers of CKD were assessed in 60% of the studies. CKD prevalence was reported by sex and age strata in 54 and 50% of the studies, respectively. In publications with a primary objective of reporting CKD prevalence, 39% reported a 95% confidence interval. Conclusions The findings from this systematic review showed considerable variation in methods for sampling the general population and assessment of kidney function across studies reporting CKD prevalence. These results are utilized to provide recommendations to help optimize both the design and the reporting of future CKD prevalence studies, which will enhance comparability of study results
6. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review
- Author
-
Brück, Katharina, Jager, Kitty J., Dounousi, Evangelia, Kainz, Alexander, Nitsch, Dorothea, Ärnlöv, Johan, Rothenbacher, Dietrich, Browne, Gemma, Capuano, Vincenzo, Ferraro, Pietro Manuel, Ferrieres, Jean, Gambaro, Giovanni, Guessous, Idris, Hallan, Stein, Kastarinen, Mika, Navis, Gerjan, Gonzalez, Alfonso Otero, Palmieri, Luigi, Romundstad, Solfrid, Spoto, Belinda, Stengel, Benedicte, Tomson, Charles, Tripepi, Giovanni, Völzke, Henry, Wiȩcek, Andrzej, Gansevoort, Ron, Schöttker, Ben, Wanner, Christoph, Vinhas, Jose, Zoccali, Carmine, Van Biesen, Wim, Stel, Vianda S., Jousilahti, Pekka, Helmer, Catherine, Metzger, Marie, Ruidavets, Jean Bernard, Bongard, Vanina, Koenig, Wolfgang, Denkinger, Michael D., Brenner, Hermann, Saum, Kai-Uwe, Nauck, Matthias, Stracke, Sylvia, Perry, Ivan, Eustace, Joseph, Lupo, Antonio, Donfrancesco, Chiara, Palleschi, Simonetta, Lamaida, Norman, Capuano, Ernesto, Sinkeler, Steef, Wolffenbuttel, B.H.R., Bakker, Stephan J.L., Aasarød, Knut, Holmen, Jostein, Chudek, Jerzy, Malgorzata, Mossakowska, Gardete-Correia, Luis, Raposo, João F., de Francisco, A.L. Martin, Gayoso Diz, P., Nerpin, Elisabet, Lind, Lars, Bochud, Murielle, Gaspoz, Jean-Michel, Fletcher, Astrid, Roderick, Paul, Van Pottelbergh, Gijs, Van Der Tol, Arjan, Hadjadj, Samy, Stojceva-Taneva, Olivera, Brück, Katharina, Jager, Kitty J., Dounousi, Evangelia, Kainz, Alexander, Nitsch, Dorothea, Ärnlöv, Johan, Rothenbacher, Dietrich, Browne, Gemma, Capuano, Vincenzo, Ferraro, Pietro Manuel, Ferrieres, Jean, Gambaro, Giovanni, Guessous, Idris, Hallan, Stein, Kastarinen, Mika, Navis, Gerjan, Gonzalez, Alfonso Otero, Palmieri, Luigi, Romundstad, Solfrid, Spoto, Belinda, Stengel, Benedicte, Tomson, Charles, Tripepi, Giovanni, Völzke, Henry, Wiȩcek, Andrzej, Gansevoort, Ron, Schöttker, Ben, Wanner, Christoph, Vinhas, Jose, Zoccali, Carmine, Van Biesen, Wim, Stel, Vianda S., Jousilahti, Pekka, Helmer, Catherine, Metzger, Marie, Ruidavets, Jean Bernard, Bongard, Vanina, Koenig, Wolfgang, Denkinger, Michael D., Brenner, Hermann, Saum, Kai-Uwe, Nauck, Matthias, Stracke, Sylvia, Perry, Ivan, Eustace, Joseph, Lupo, Antonio, Donfrancesco, Chiara, Palleschi, Simonetta, Lamaida, Norman, Capuano, Ernesto, Sinkeler, Steef, Wolffenbuttel, B.H.R., Bakker, Stephan J.L., Aasarød, Knut, Holmen, Jostein, Chudek, Jerzy, Malgorzata, Mossakowska, Gardete-Correia, Luis, Raposo, João F., de Francisco, A.L. Martin, Gayoso Diz, P., Nerpin, Elisabet, Lind, Lars, Bochud, Murielle, Gaspoz, Jean-Michel, Fletcher, Astrid, Roderick, Paul, Van Pottelbergh, Gijs, Van Der Tol, Arjan, Hadjadj, Samy, and Stojceva-Taneva, Olivera
- Abstract
Background Many publications report the prevalence of chronic kidney disease (CKD) in the general population. Comparisons across studies are hampered as CKD prevalence estimations are influenced by study population characteristics and laboratory methods. Methods For this systematic review, two researchers independently searched PubMed, MEDLINE and EMBASE to identify all original research articles that were published between 1 January 2003 and 1 November 2014 reporting the prevalence of CKD in the European adult general population. Data on study methodology and reporting of CKD prevalence results were independently extracted by two researchers. Results We identified 82 eligible publications and included 48 publications of individual studies for the data extraction. There was considerable variation in population sample selection. The majority of studies did not report the sampling frame used, and the response ranged from 10 to 87%. With regard to the assessment of kidney function, 67% used a Jaffe assay, whereas 13% used the enzymatic assay for creatinine determination. Isotope dilution mass spectrometry calibration was used in 29%. The CKD-EPI (52%) and MDRD (75%) equations were most often used to estimate glomerular filtration rate (GFR). CKD was defined as estimated GFR (eGFR) <60 mL/min/1.73 m2 in 92% of studies. Urinary markers of CKD were assessed in 60% of the studies. CKD prevalence was reported by sex and age strata in 54 and 50% of the studies, respectively. In publications with a primary objective of reporting CKD prevalence, 39% reported a 95% confidence interval. Conclusions The findings from this systematic review showed considerable variation in methods for sampling the general population and assessment of kidney function across studies reporting CKD prevalence. These results are utilized to provide recommendations to help optimize both the design and the reporting of future CKD prevalence studies, which will enhance comparability of study results
7. CKD Prevalence Varies across the European General Population.
- Author
-
Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, and Jager KJ
- Subjects
- Adult, Aged, Aged, 80 and over, Europe epidemiology, Female, Humans, Kidney Failure, Chronic epidemiology, Male, Middle Aged, Prevalence, Severity of Illness Index, Young Adult, Renal Insufficiency, Chronic epidemiology
- Abstract
CKD prevalence estimation is central to CKD management and prevention planning at the population level. This study estimated CKD prevalence in the European adult general population and investigated international variation in CKD prevalence by age, sex, and presence of diabetes, hypertension, and obesity. We collected data from 19 general-population studies from 13 European countries. CKD stages 1-5 was defined as eGFR<60 ml/min per 1.73 m(2), as calculated by the CKD-Epidemiology Collaboration equation, or albuminuria >30 mg/g, and CKD stages 3-5 was defined as eGFR<60 ml/min per 1.73 m(2) CKD prevalence was age- and sex-standardized to the population of the 27 Member States of the European Union (EU27). We found considerable differences in both CKD stages 1-5 and CKD stages 3-5 prevalence across European study populations. The adjusted CKD stages 1-5 prevalence varied between 3.31% (95% confidence interval [95% CI], 3.30% to 3.33%) in Norway and 17.3% (95% CI, 16.5% to 18.1%) in northeast Germany. The adjusted CKD stages 3-5 prevalence varied between 1.0% (95% CI, 0.7% to 1.3%) in central Italy and 5.9% (95% CI, 5.2% to 6.6%) in northeast Germany. The variation in CKD prevalence stratified by diabetes, hypertension, and obesity status followed the same pattern as the overall prevalence. In conclusion, this large-scale attempt to carefully characterize CKD prevalence in Europe identified substantial variation in CKD prevalence that appears to be due to factors other than the prevalence of diabetes, hypertension, and obesity., (Copyright © 2016 by the American Society of Nephrology.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.